Table 8.
Group (n = 4–5) | 1 | 2 | 3 | 4 | 5 |
---|---|---|---|---|---|
MMP-9/β-actin | 1.00 ± 0.00 | 5.03 ± 1.57** | 3.05 ± 0.88† | 1.35 ± 0.41†† | 1.49 ± 0.47†† |
The ratios of the protein expression levels of MMP-9 relative to that of β-actin
This study included 5 Groups, namely, Group 1 (the sham procedure retina) as well as Groups 2, 3, 4 and 5 [(the retina subjected to ischemia plus reperfusion respectively pretreated with vehicle (I/R + vehicle), 2.8 g/kg/day of CJDHW (I/R + CJDHW2.8), 4.2 g/kg/day of CJDHW (I/R + CJDHW4.2) and SB203580 (p38 MAPK inhibitor)]
CJDHW Chi-Ju-Di-Huang-Wan
** indicates significance (P < 0.01; Group 1 vs. 2)
†† indicates significance (P < 0.01; Group 2 vs. 4; Group 2 vs. 5). †indicates significance (P < 0.05; Group 2 vs. 3). The results are mean ± SD (n = 4–5)